Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
SLS
SELLAS Life Sciences Group, Inc.
NASDAQ · Pharmaceutical Preparations
Last close
$12.31
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$2.49B
RECENT INSIDER TRADES
2025-11-21
· Kalin Katherine Bach
(Director)
· BUY
2025-06-13
· VAN NOSTRAND ROBERT L
(Director)
· BUY
2025-06-02
· Wasman Jane
(Director)
· BUY
2025-05-22
· Kalin Katherine Bach
(Director)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
200
Shares held
82,739,764
Value
$1.10B
Percent of shares outstanding
40.97%
As of quarter end
2026-06-30
RECENT NEWS
SLS: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS
SELLAS Life Sciences presents SLS009 pancreatic cancer data at AACR
SLS: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS
Sellas Life Sciences: Valued For Perfection, REGAL Trial Success Probability Priced In
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
SELLAS Life Sciences Group, Inc. (SLS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit